The Former FDA team has been featured on Scientific American, CNN, CBS News, Wired Magazine, The Scientist, HealthNewsReview.org, U.S. News & World Report, The Washington Post, Fortune, International Business Times, Wall Street Journal, Boston Globe, and on NPR radio.
The team also has publications in the Journal of the American College of Surgeons, Journal of Surgery, Endothelium the Journal of Endothelial Cell Research.
“FormerFDA is a team of medical officers, research scientists, drug safety experts and drug reviewers formerly with the FDA.
[The FDA] could be working a lot more efficiently, FormerFDA says. The agency is overwhelmed with an overbearing amount of federal regulations, which have not kept pace with innovation.”
“FormerFDA, a team of past U.S. Food and Drug Administration medical officers, told CBS News that the FDA does not have the authority to regulate dietary supplements from other countries that come through the mail. Typically, only when something goes wrong can the FDA take action.
Members of the team worked at the agency’s division of metabolism and endocrinology that reviews drugs for weight loss, and are currently a drug safety experts who consult lawyers on FDA regulations.”
“FormerFDA medical law consulting agency, points out that patients or insurers still have to pay for an analysis to determine whether the disease they have is truly caused by the gene targeted by a new drug. And since many new genetically-based medicines may only work in a handful of patients, companies may not feel there is sufficient incentive to develop these drugs in the first place. ”
Interviews or answers for complex FDA / drug development / drug safety / pharmacology questions for our experts is a free service we offer to assist others in understanding complex drug development process
You may contact 202-248-2777, and you will be placed in touch with an expert on the same day.